Frequent headaches can interfere with concentration, meetings, screen work, driving, sleep, and the ability to finish a normal workday, but “frequent headache” is not a diagnosis by itself. The underlying pattern may be migraine, tension-type headache, medication-overuse headache, or a secondary headache caused by another medical problem. Migraine, for example, is a neurological disorder that may involve throbbing or pressure-like pain, nausea, sensitivity to light or sound, fatigue, and difficulty concentrating, with attacks that can vary substantially from one person to another. The NINDS migraine overview explains that treatment generally has two separate goals: controlling individual attacks and reducing the frequency of future episodes.
For a working adult whose headaches have become a regular part of the week, the useful question is therefore not simply “Which painkiller should I take?” A better approach is to count how often headaches occur, identify the pattern, determine whether acute medicines are being used too frequently, and decide whether preventive treatment should become part of the plan.
Count Headache Days Before Counting Painkillers
The number of headache days per month changes how the problem is evaluated. Headache occurring on 15 or more days per month for at least three months falls into the chronic daily headache range, although the underlying diagnosis still has to be established. The Cleveland Clinic chronic headache definition describes this frequency threshold and the different disorders that can produce near-daily pain.
A simple headache record is often more useful than trying to remember several weeks of symptoms during an appointment. NICE recommends recording headache frequency, duration, severity, associated symptoms, possible triggers, and every prescription or over-the-counter medicine used for relief. Keeping a headache diary for several weeks can show whether attacks cluster around particular workdays, sleep schedules, meals, menstrual cycles, or medication use.
| Record | Why It Matters |
|---|---|
| Headache days per month | Helps distinguish occasional attacks from a high-frequency or chronic pattern. |
| Duration | Shows whether pain lasts an hour, most of the workday, or continues into the next day. |
| Associated symptoms | Nausea, light sensitivity, visual symptoms, or worsening with normal activity may suggest migraine. |
| Medicines used | Frequent acute treatment can itself contribute to increasing headache frequency. |
| Workday pattern | Skipped meals, glare, long screen sessions, caffeine changes, and irregular sleep may identify modifiable contributors. |
Separate Migraine From the Typical End-of-Day Headache
Tension-type headache commonly produces bilateral pressure or tightening without the prominent nausea and activity-related worsening typical of migraine. Migraine may be one-sided or bilateral and often interferes more substantially with routine activity. Severe pain around one eye accompanied by tearing, nasal symptoms, or marked restlessness suggests another pattern and deserves specific evaluation. The VA/DoD headache guideline provides a clinical framework for distinguishing common headache disorders before treatment is selected.
Work can influence when symptoms appear without necessarily being the underlying cause. Excessive screen glare and poorly positioned lighting can contribute to eye strain and headache, while prolonged awkward neck posture can add muscular discomfort.
OSHA guidance on workstation lighting recommends reducing reflected glare and excessive contrast around monitors. A headache that repeatedly appears at work should still be evaluated on its clinical features rather than automatically labeled a “screen headache” or stress headache.
Pharmacologic Treatment for Acute Headache Attacks
For an occasional tension-type headache, acetaminophen, aspirin, or a nonsteroidal anti-inflammatory drug such as ibuprofen or naproxen may be sufficient when medically appropriate. Migraine attacks may also respond to these medicines, particularly when symptoms are relatively mild. Evidence reviewed for acute migraine treatment supports NSAIDs and triptans among established acute options.
When ordinary analgesics do not provide adequate migraine relief, clinicians may consider migraine-specific prescription treatment. The choice depends on cardiovascular history, previous response, other medicines, pregnancy considerations, and the characteristics of the attacks.
| Option | Role | Important Considerations |
|---|---|---|
| Acetaminophen | Acute relief for selected mild headaches or migraine attacks | Excessive total daily exposure can cause serious liver injury. |
| Ibuprofen or naproxen | Acute treatment for tension-type headache and migraine | GI bleeding, kidney disease, cardiovascular risk, and anticoagulant use may limit suitability. |
| Sumatriptan | Migraine-specific acute treatment | Generally avoided in certain cardiovascular and cerebrovascular conditions. |
| Ubrogepant | Acute CGRP-receptor antagonist for migraine | Drug interactions and liver or kidney impairment can affect use. |
| Antiemetics | May be added when nausea or vomiting accompanies migraine | The specific medicine determines adverse effects and interactions. |
For working adults who rely on an established migraine prescription, planning refills around busy workweeks, business travel, or irregular schedules may include using a mail-order service such as Global Canadian Pharmacy to maintain regular access to preventive migraine medicines (Topiramate, Propranolol, Atogepant, Pimegepant) and to keep an appropriate supply of prescribed acute treatments available for headache attacks during the workday.
Sumatriptan is available in several formulations, which can matter when a working adult needs an acute treatment that fits the characteristics of an attack. Oral tablets are commonly available in 25 mg, 50 mg, and 100 mg strengths, while nasal and injectable formulations also exist. Its current sumatriptan label identifies it for acute migraine treatment rather than prevention. Depending on route and individual response, benefit may begin within minutes to roughly an hour.
Ubrogepant is an oral CGRP receptor antagonist used during a migraine attack and is available as 50 mg and 100 mg tablets. Unlike triptans, its mechanism does not depend on vasoconstriction. The current FDA ubrogepant label includes important interaction considerations involving strong CYP3A4 inhibitors and other medicines that can change drug exposure.
When Headache Days Keep Returning, Prevention Becomes the Main Job
Repeatedly treating each attack may be inadequate when migraine is frequent, disabling, prolonged, or difficult to control with acute medication. Preventive treatment is intended to reduce future headache frequency, severity, or disability. Options include medicines originally developed for other conditions as well as migraine-specific therapies.
Traditional choices may include propranolol or metoprolol, topiramate, amitriptyline, venlafaxine, and selected other agents. Their side-effect profiles matter to working adults.
Beta blockers may cause fatigue or low blood pressure, topiramate can cause cognitive slowing or tingling, and amitriptyline can produce sedation and dry mouth.
CGRP-targeting treatments have changed the preventive landscape. The American Headache Society’s updated position on CGRP prevention considers monoclonal antibodies such as erenumab, fremanezumab, galcanezumab, and eptinezumab, as well as preventive gepants such as atogepant and rimegepant, appropriate first-line preventive options without requiring failure of older drug classes first.
Not every guideline sequences these medicines identically. The American College of Physicians’ 2025 prevention guideline for episodic migraine begins with selected established medicines and places CGRP-targeting treatment after inadequate response or intolerance. In practice, selection can depend on headache burden, comorbidities, adverse effects, insurance requirements, pregnancy potential, and previous treatment history. OnabotulinumtoxinA is another established preventive option for appropriately diagnosed chronic migraine.
Check Whether the Rescue Medicine Is Becoming Part of the Problem
A common mistake in people trying to remain functional at work is to treat every headache with another dose of acute medicine without tracking the total number of treatment days. Medication-overuse headache can develop when acute treatments are used too frequently over time. The risk differs by drug class, but repeated use of triptans, combination analgesics, opioids, and even ordinary analgesics can contribute. The American Migraine Foundation’s medication overuse guidance recommends medical review when headache frequency and reliance on acute medication are increasing.
This is one reason preventive treatment becomes important. The objective is not simply to find a stronger rescue medicine but to reduce the number of days on which rescue treatment is needed.
Change the Workday Without Assuming Lifestyle Measures Are Enough
Regular meals, adequate hydration, consistent sleep, planned breaks from prolonged screen work, and avoiding large day-to-day changes in caffeine intake can reduce avoidable triggers for some people. These measures are useful adjuncts, but a person with frequent migraine should not be told that posture, hydration, or stress management alone will necessarily solve a neurological headache disorder.
Behavioral approaches can be added when appropriate. Evidence on non-drug approaches suggests potential benefit from techniques including biofeedback, relaxation training, and acupuncture for some headache disorders, although the strength of evidence varies by intervention.
Bring Work Impact Into the Medical Appointment
A useful clinical discussion should include more than the pain score. Tell the clinician how many workdays are affected, whether attacks require leaving meetings or stopping screen work, whether concentration becomes difficult, how often acute medicine is needed, and whether headache is present on waking or appears later in the day. This information helps distinguish an occasional problem from a headache disorder that may justify preventive treatment.
Medical assessment may also include blood pressure, neurological examination, medication review, sleep history, vision-related symptoms, and selected testing when another cause is suspected.
Routine brain imaging is not required simply because headaches recur when the clinical pattern is typical of a primary headache disorder and the examination is reassuring.
Do Not Work Through New Warning Signs
Frequent familiar headaches can often be assessed through routine care, but certain changes require faster evaluation. A sudden headache reaching maximum intensity within minutes, new weakness or numbness, difficulty speaking, confusion, loss of consciousness, fever with worsening headache, a substantial change in the usual pattern, recent significant head injury, or new headache associated with persistent vomiting should not be managed simply with another workday dose of pain medicine.
The practical sequence for a working adult is straightforward: document the pattern, establish the headache type, use acute medication selectively, watch for medication overuse, and move toward preventive treatment when headache days continue to accumulate. Workplace adjustments can remove avoidable triggers, but persistent or disabling headaches deserve a medical strategy designed around both attack control and prevention.
